Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Japanese patent covers Kanebo's new Na+/H+ exchange inhibitors

May 17, 2000

New series of ECE inhibitors in early development by Sumitomo

May 17, 2000

Uniprost to be marketed by Ferrer in Europe and Latin America

May 17, 2000

Free radical scavenger T-0162 protects against ischemia/reperfusion myocardial injury

May 16, 2000

PCO prodrugs with slow onset and long duration of action presented by Daiichi

May 16, 2000

New isosorbide mononitrate derivatives with reduced tolerance under study at Lacer

May 16, 2000

Compounds and methods for treating atherosclerosis and other coronary artery diseases

May 16, 2000

Potent CETP inhibitors in the Pharmacia pipeline

May 16, 2000

United Therapeutics to begin Flolan-to-Uniprost transition study

May 15, 2000

TP-10 phase I/II study results presented at cardiovascular anesthesiology meeting

May 15, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...